R. Asciak (Attard, Malta), P. Postmus (LEIDEN, Netherlands), F. Rodriguez Panadero (Tomares (Sevilla), Spain)
Early pleural fluid control is warranted to prevent reaccumulation of malignant pleural effusion in oncogene-driven lung cancer
M. Lui (Hong Kong, Hong Kong), K. Chiang (Hong Kong, Hong Kong), C. Ho (Hong Kong, Hong Kong), C. Tam (Hong Kong, Hong Kong), C. Lam (Hong Kong, Hong Kong), Y. Lee (Hong Kong, Hong Kong), S. Ip (Hong Kong, Hong Kong)
|     |
Elevated circulating activin A levels in malignant pleural mesothelioma patients are related to cancer cachexia and poor response to platinum-based chemotherapy
J. Paajanen (Helsinki, Finland), I. Ilonen (HELSINKI, Finland), H. Lauri (HELSINKI, Finland), T. Järvinen (HELSINKI, Finland), E. Sutinen (HELSINKI, Finland), H. Ollila (HELSINKI, Finland), E. Rouvinen (HELSINKI, Finland), K. Lemström (HELSINKI, Finland), J. Räsänen (HELSINKI, Finland), O. Ritvos (HELSINKI, Finland), K. Koli (HELSINKI, Finland), M. Myllärniemi (HELSINKI, Finland)
| |
The incidence of Malignancy and Survival in Patients with Idiopathic Pleuritis
S. Reuter (Naestved, Denmark), P. Clementsen (Roskilde, Denmark), U. Bodtger (Naestved, Denmark)
| |
Exploration of breath analysis to monitor therapeutic response in mesothelioma patients
E. Janssens (Antwerp, Belgium), J. Van Meerbeeck (Antwerp, Belgium), K. Lamote (Antwerp, Belgium)
| |
Patient derived pleural mesothelioma cell lines, can be used as tools, to guide patient stratification
N. Kanellakis (Oxford, United Kingdom), R. Asciak (Oxford, United Kingdom), X. Yao (Oxford, United Kingdom), Y. Peng (Oxford, United Kingdom), M. Mccole (Oxford, United Kingdom), S. Mcgowan (Oxford, United Kingdom), R. Mercer (Oxford, United Kingdom), R. Hallifax (Oxford, United Kingdom), T. Sherrill (Nashville, United States of America), F. Maldonado (Nashville, United States of America), D. Ebner (Oxford, United Kingdom), T. Blackwell (Nashville, United States of America), G. Stathopoulos (Patras, Greece), T. Dong (Oxford, United Kingdom), N. Rahman (Oxford, United Kingdom), I. Psallidas (Oxford, United Kingdom)
| |
Malignant pleural effusion survival prognostication in an Asian population
J. Quek (Singapore, Singapore), Q. Tan (Singapore, Singapore), J. Wong (Singapore, Singapore), J. Carter (Singapore, Singapore), D. Anantham (Singapore, Singapore)
| |
Effects of 2-Deoxy-glucose (2DG) with cisplatin and pemetrexed in mesothelioma cell mediated collagen gel contraction.
I. Gerogianni (Larissa, Greece), R. Jagirdar (Larissa, Greece), E. Pitaraki (Larissa, Greece), O. Kouliou (Larissa, Greece), C. Hatzoglou (Larissa, Greece), K. Gourgoulianis (Larissa, Greece), S. Zaroginannis (Larissa, Greece)
| |
Neuro-cognitive (HVLT-R total recall) functioning in localized vs. metastatic small-cell lung cancer with or without hippocampus sparing PCI: Results from a phase III trial
J. van Meerbeeck (Edegem, Belgium), D. De Ruysscher (Maastricht, Netherlands), J. Belderbos (Amsterdam, Netherlands), K. De Jaeger (Eindhoven, Netherlands), F. Koppe (Tilburg, Netherlands), M. Lambrechts (Leuven, Belgium), Y. Lievens (Ghent, Belgium), E. Dieleman (Amsterdam, Netherlands), J. Jaspers (Rotterdam, Netherlands), J. Ubbels (Groningen, Netherlands), M. Kwint (Maastricht, Netherlands), M. Kuenen (Amsterdam, Netherlands), S. Deprez (Leuven, Belgium), M. De Ruiter (Amsterdam, Netherlands), K. Sikorska (Amsterdam, Netherlands), H. Van Tinteren (Amsterdam, Netherlands), S. Schagen (Amsterdam, Netherlands)
| |